The presently demonstrated role of CFTR in regulation of glucagon-production related genes (i.e., glucagon and PC2) may underlie the pathogenesis of the glucagon level disruption seen in CF patients with diabetes (Hinds et al., 1991; Lanng et al., 1993; Edlund et al., 2017). The gene discussed is CFTR; the disease is diabetes mellitus.